Nonopioid Analgesia After Labral Surgery

ConditionNarcotic Use
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorHenry Ford Health System

About this trial

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

All adult patients over age 18 and scheduled for a primary or revision labral surgery

Disqualifiers

Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact rotator cuff

Trial design

Design model

Parallel

Treatments tested in this trial

  • Celecoxib

    Drug

    Post-Operative Non Opioid Pain Protocol

  • Hydrocodone-Acetaminophen

    Drug

    Traditionally used narcotic pain protocol

  • Ketorolac

    Drug

    Post-Operative Non Opioid Pain Protocol

  • Gabapentin

    Drug

    Post-Operative Non Opioid Pain Protocol

  • Acetaminophen

    Drug

    Post-Operative Non Opioid Pain Protocol

  • Diazepam

    Drug

    Post-Operative Non Opioid Pain Protocol

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Post-Operative Non Opioid Pain ProtocolExperimental treatment 5 interventions
Group B: Post-Operative Traditional Pain ProtocolActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain Levels

Patients recorded pain levels 3 times per day using Visual analog scales until study completion. Average daily pain was calculated for each patient. Higher values portend worse control.

Time frame
10 days post-operatively
2

Patient-Reported Outcomes Measurement Information System

Patient-Reported Outcomes Measurement Information System Physical Interference (PROMIS PI) nightly until study completion. Average PROMIS PI values calculated nightly. A higher score indicates more pain interference.

Time frame
10 days post-operatively

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.